These results altogether indicate that the previous effects reported on the mechanisms of action of ChoKα inhibitors either on MAPK, AKT and ceramides signaling are not responsible for the synergistic effect observed in colon cancer cells when combining ChoKα inhibitors and 5-FU. The gene discussed is AKT1; the disease is colonic neoplasm.